GSK2879552
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- Lysine Demethylase inhibitor
- Produktmerkmale
- GSK289552 is potent, selective, and irreversible inhibitor of Lysine Demethylase 1 (LSD1) via covalent modification of the LSD1 cofactor FAD (Ki = 1.7 μM). It is selective for LSD1 over the closely related LSD2, MAO-A, MAO-B, and the FAD dependent enzymes D-amino acid oxidase and glutathione reductase. Tested against a panel of 165 cancer cell lines, GSK2879552 inhibited the proliferation of 9 small cell lung carcinoma lines and 20 AML cell lines.
- Reinheit
- >98 %
- Chemical Name
- 4-[[4-[[[(1R,2S)-2-Phenylcyclopropyl]amino]methyl]-1-piperidinyl]methyl]benzoic acid dihydrochloride
- Formel
- C23H28N2O2 •2HCl
- Löslichkeit
- Soluble in DMSO (up to 25 mg/ml) and in Water (up to at least 25 mg/ml)
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Lagerung
- -20 °C
-
- Hintergrund
- Epigenetics,Proliferation,Protein demethylase,Cancer,Posttranslational modification,Chromatin
- Molekulargewicht
- 437.40
- CAS-Nummer
- 1401966-69-5
-